Mei Liu

Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles.

Kaili Hu, Liping Wang, Jianfang Feng, 2019, Nanomedicine.

Natural products: Potential therapeutic agents in multiple sclerosis.

Kaili Hu, Mei Liu, Shuangwen Yu, 2019, International immunopharmacology.

Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles

Kaili Hu, Jianfang Feng, Mei Liu, 2021, International journal of nanomedicine.

The Role of CD4+ T Cells in the Immunotherapy of Brain Disease by Secreting Different Cytokines

Kaili Hu, Mei Liu, Jing Wang, 2022, Journal of Neuroimmune Pharmacology.

Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy

Jun Chen, Kaili Hu, Jianfang Feng, 2017, Acta pharmaceutica Sinica. B.

Chitosan and chitosan coating nanoparticles for the treatment of brain disease

Kaili Hu, Jianfang Feng, Mei Liu, 2019, International journal of pharmaceutics.

Nose to brain delivery of Astragaloside IV by β-Asarone modified chitosan nanoparticles for multiple sclerosis therapy.

Kaili Hu, Xiao Zhao, Mei Liu, 2023, International journal of pharmaceutics.

Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury

Kaili Hu, Jianfang Feng, Xiao Zhao, 2021, Drug delivery.